Company Analysis Shanghai Junshi Biosciences Co., Ltd.
1. Summary
Advantages
- Price (25.14 Β₯) is less than fair price (41.49 Β₯)
- Current debt level 12.23% is below 100% and has decreased over 5 years from 18.58%.
Disadvantages
- Dividends (0%) are below the sector average (0.3991%).
- The stock's return over the last year (-35.53%) is lower than the sector average (-14.83%).
- The company's current efficiency (ROE=-27.37%) is lower than the sector average (ROE=6.65%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Shanghai Junshi Biosciences Co., Ltd. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -5.7% | -0.1% | 2.5% |
| 90 days | -16.4% | -3.7% | -2.6% |
| 1 year | -35.5% | -14.8% | 26.2% |
688180 vs Sector: Shanghai Junshi Biosciences Co., Ltd. has significantly underperformed the "Healthcare" sector by -20.7% over the past year.
688180 vs Market: Shanghai Junshi Biosciences Co., Ltd. has significantly underperformed the market by -61.74% over the past year.
Stable price: 688180 is not significantly more volatile than the rest of the market on "Shanghai Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 688180 with weekly volatility of -0.6833% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (25.14 Β₯) is lower than the fair price (41.49 Β₯).
Price significantly below the fair price: The current price (25.14 Β₯) is 65% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (41.44).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (64.64).
4.3. P/BV
P/BV vs Sector: The company's P/BV (5.51) is higher than that of the sector as a whole (3.68).
P/BV vs Market: The company's P/BV (5.51) is higher than that of the market as a whole (3.08).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (26.9) is higher than that of the sector as a whole (20.2).
P/S vs Market: The company's P/S indicator (26.9) is higher than that of the market as a whole (6.41).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-12.44) is lower than that of the sector as a whole (16.62).
EV/Ebitda vs Market: The company's EV/Ebitda (-12.44) is lower than that of the market as a whole (17.31).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 7.4% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (7.4%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0%).
5.4. ROE
ROE vs Sector: The company's ROE (-27.37%) is lower than that of the sector as a whole (6.65%).
ROE vs Market: The company's ROE (-27.37%) is lower than that of the market as a whole (8.24%).
5.5. ROA
ROA vs Sector: The company's ROA (-19.06%) is lower than that of the sector as a whole (3.59%).
ROA vs Market: The company's ROA (-19.06%) is lower than that of the market as a whole (4.08%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.3991%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
